Starts & Stops: FDA Approves Medtronic's Plan For 340-Patient Renal Denervation Trial
Executive Summary
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from Nov. 5 through Nov. 11, including trial announcements from Medtronic, Evaheart, and VentureMed.